Oncotelic Therapeutics, Inc. (OTLC) stock
OTLCOTCPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 6/30
$0.02+0.00 (+11.45%)
Close on Oct 19, 2026Market cap $8.66MP/E 0.0Yield –
Oncotelic Therapeutics revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Oncotelic Therapeutics's revenue for the twelve months ending Dec 31, 2023 was $70.00K. For fiscal 2023 it was $70.00K, down 96.0% from the year before.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | $70.00K | -96.0% |
| FY2020 | Dec 31, 2020 | $1.74M | +1732.5% |
| FY2013 | Dec 31, 2013 | $95.00K | -39.1% |
| FY2012 | Dec 31, 2012 | $156.00K | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $250.00K | – |
| Q4 FY2023 | Dec 31, 2023 | $0 | -100.0% |
| Q3 FY2023 | Sep 30, 2023 | $70.00K | -79.5% |
| Q4 FY2020 | Dec 31, 2020 | $0 | – |
| Q3 FY2020 | Sep 30, 2020 | $0 | – |
| Q2 FY2020 | Jun 30, 2020 | $1.40M | – |
| Q1 FY2020 | Mar 31, 2020 | $340.86K | – |
See a number that looks wrong?